TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8016425

Group type: EXPERIMENTAL
Intervention: Thiopental 4 mg/kg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Propofol 2 mg/kg
Number of subjects: 100
Study: 2314578

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Phenobarbital
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Phenytoin
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 15
Study: 372867

Group type: EXPERIMENTAL
Intervention: Diclofenac 25 mg q.i.d.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Aspirin 750 mg q.i.d.
Number of subjects: 24
Study: 31989580

Group type: EXPERIMENTAL
Intervention: Behavioural change programme plus moisturizing creams
Number of subjects: 2040

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 2040
Study: 31407876

Group type: EXPERIMENTAL
Intervention: Individualized multicomponent exercise training programme (performed during 5-7 consecutive days, two sessions/day)
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Individualized multicomponent exercise training programme
Number of subjects: 370

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Intervention group (exercise intervention)
Number of subjects: 370
Study: 28295451

Group type: EXPERIMENTAL
Intervention: GSK3050002 (0.1-20 mg kg-1)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: GSK3050002 (5 mg kg-1 and higher)
Number of subjects: 48

Group type: COMPARATOR
Intervention: GSK3050002
Number of subjects: 48
Study: 25850127

Group type: EXPERIMENTAL
Intervention: Clinical Integrative Puzzle (CIP)
Number of subjects: 36
Study: 23802878

Group type: EXPERIMENTAL
Intervention: Brief Intervention Group (BIG)
Number of subjects: 476

Group type: COMPARATOR
Intervention: Contact Control Group (CCG)
Number of subjects: 476

Group type: COMPARATOR
Intervention: No-Contact Control Group (NCG)
Number of subjects: 476
Study: 21193422

Group type: EXPERIMENTAL
Intervention: 100 μg of vitamin K(1)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: 150 μg of vitamin K(1)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: 200 μg of vitamin K(1)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 19811532

Group type: EXPERIMENTAL
Intervention: Fasted state (15.9 +/- 0.3 h since supper)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fed state (1.6 +/- 0.1 h since breakfast)
Number of subjects: 20
Study: 17050012

Group type: EXPERIMENTAL
Intervention: Physical training (30 min cycling at 60-70% of peak oxygen consumption for 5 days/week for 6 months)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Physical training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 15022805

Group type: EXPERIMENTAL
Intervention: 150 mg cholestyramine-bound diclofenac (2 x 1 capsule Voltaren resinate) daily for 14 days
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: 75 mg cholestyramine-bound diclofenac (1 x 1 capsule) daily for 14 days
Number of subjects: 245

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Lower dose (75 mg)
Number of subjects: 245
Study: 11255384

Group type: COMPARATOR
Intervention: Placebo (n = 29)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Nortriptyline (target steady-state level, 75-125 ng/mL) (n = 27)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Nortriptyline-lithium combination (target steady-state level, 0.5-0.9 mEq/L) (n = 28)
Number of subjects: 84
Study: 9544650

Group type: EXPERIMENTAL
Intervention: Adjunctive mitomycin C (MMC)
Number of subjects: 49

Group type: COMPARATOR
Intervention: No adjunctive mitomycin C (SGTP control)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Primary glaucoma triple procedure (PGTP)
Number of subjects: 49
Study: 7531355

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 11
Study: 2582838

Group type: EXPERIMENTAL
Intervention: Fenoterol (400 micrograms, 600 micrograms, and 800 micrograms administered at 15-minute intervals, total dose 1.8 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Theophylline alone
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Fenoterol
Number of subjects: 8
Study: 825778

Group type: EXPERIMENTAL
Intervention: Hexamethylmelamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Melphalan
Number of subjects: 0
Study: 31609667

Group type: EXPERIMENTAL
Intervention: IPL + RF combination therapy
Number of subjects: 47

Group type: COMPARATOR
Intervention: IPL
Number of subjects: 47

Group type: COMPARATOR
Intervention: RF
Number of subjects: 47
Study: 31476481

Group type: EXPERIMENTAL
Intervention: Duloxetine (60 mg, 2 doses: 2 hours before and 24 hours after surgery)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (2 doses, 2 hours before and 24 hours after surgery)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 30379386

Group type: EXPERIMENTAL
Intervention: Healthy lifestyle intervention including brief advice, clinical consultation, and referral to a 6-month telephone-based coaching service
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 160
Study: 28834070

Group type: EXPERIMENTAL
Intervention: Patient Navigation (PN)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Standard Care (Control)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Overall Health Care Costs
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Primary Care Physician (PCP) Visits
Number of subjects: 282
Study: 26056920

Group type: EXPERIMENTAL
Intervention: Gluten-containing group (35 cases)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo group (37 cases)
Number of subjects: 148
Study: 23527941

Group type: EXPERIMENTAL
Intervention: Pro-AMED group
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Occasional AMED group
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Anti-AMED group
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Strong peer influence group
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: AMED-specific messages in brief interventions
Number of subjects: 387
Study: 20543765

Group type: EXPERIMENTAL
Intervention: Total Disc Replacement (TDR)
Number of subjects: 454

Group type: COMPARATOR
Intervention: Anterior Cervical Discectomy and Fusion (ACDF)
Number of subjects: 454
Study: 19967902

Group type: EXPERIMENTAL
Intervention: Brief motivational intervention
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: High self-efficacy
Number of subjects: 107
Study: 17105693

Group type: EXPERIMENTAL
Intervention: Homeopathic arnica (1 x 5 globules of dilution 30x before surgery and 3 x 5 globules daily after surgery)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Placebo (1 x 5 globules before surgery and 3 x 5 globules daily after surgery)
Number of subjects: 319
Study: 15612850

Group type: EXPERIMENTAL
Intervention: Lifestyle Management Class (LMC)
Number of subjects: 0
Study: 11534876

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 32
Study: 9403152

Group type: EXPERIMENTAL
Intervention: Cambridge Contextual Reading Test (CCRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spot‐the‐Word Test
Number of subjects: 0

Group type: COMPARATOR
Intervention: National Adult Reading Test (NART)
Number of subjects: 0
Study: 8240617

Group type: EXPERIMENTAL
Intervention: Term Guard monitoring system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 3554095

Group type: EXPERIMENTAL
Intervention: High frequency neural modulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31991636

Group type: EXPERIMENTAL
Intervention: Extremely Randomized Trees algorithm with IMU sensor data sampled at 50 Hz and 5-s windows
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline of smartphone non-use while sitting and walking
Number of subjects: 0
Study: 29440881

Group type: EXPERIMENTAL
Intervention: Trunk orthosis with joints providing resistive force (TORF)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Corset (control group)
Number of subjects: 28
Study: 26350603

Group type: EXPERIMENTAL
Intervention: Nasal pressure (NP)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Transformed nasal pressure (transformed NP)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Respiratory inductive plethysmography (RIP) flow
Number of subjects: 15
Study: 24346102

Group type: EXPERIMENTAL
Intervention: 200 mg LY293111
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 600 mg LY293111
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 23736006

Group type: EXPERIMENTAL
Intervention: High monounsaturated fat hypocaloric diet (diet M)
Number of subjects: 260

Group type: COMPARATOR
Intervention: High polyunsaturated fat hypocaloric diet (diet P)
Number of subjects: 260
Study: 20733212

Group type: EXPERIMENTAL
Intervention: Hoped-for possible selves intervention
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Feared possible selves intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control condition (quiz about physical activity)
Number of subjects: 80
Study: 18506165

Group type: EXPERIMENTAL
Intervention: Panitumumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Panitumumab alongside chemotherapy
Number of subjects: 0
Study: 15890169

Group type: EXPERIMENTAL
Intervention: Training to interpret emotionally ambiguous passages in a negative direction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Training to interpret emotionally ambiguous passages in a positive direction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Training effects over time spans of up to 1 day
Number of subjects: 0
Study: 12814281

Group type: EXPERIMENTAL
Intervention: Social/sexual expectancy‐challenge intervention
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 46
Study: 11027880

Group type: EXPERIMENTAL
Intervention: Proton magnetic resonance spectroscopy (MRS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (13 controls)
Number of subjects: 30
Study: 9119942

Group type: EXPERIMENTAL
Intervention: Face-to-face communication task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Audio-only communication task
Number of subjects: 0
Study: 1639583

Group type: EXPERIMENTAL
Intervention: Condress (patented sheets of pure bovine collagen)
Number of subjects: 45
Study: 6748071

Group type: EXPERIMENTAL
Intervention: EMG training on the forehead (frontal area)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: EMG training on the frontal area, neck (sternomastoid), and forearm areas in succession
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: EMG training with relaxation instructions used at home
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Other measures (peripheral temperatures and self-reported anxiety)
Number of subjects: 32
Study: 31126419

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 29385147

Group type: EXPERIMENTAL
Intervention: Nabiximols (up to 113.4 mg THC/105 mg CBD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nabiximols
Number of subjects: 40
Study: 27130175

Group type: EXPERIMENTAL
Intervention: Core strategy for promoting change
Number of subjects: 36

Group type: COMPARATOR
Intervention: Enhanced strategy (Core + active facilitation)
Number of subjects: 36
Study: 24634423

Group type: EXPERIMENTAL
Intervention: Daily bathing instructions
Number of subjects: 28

Group type: COMPARATOR
Intervention: Twice a week bathing instructions
Number of subjects: 28
Study: 22221014

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75%
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 20585106

Group type: EXPERIMENTAL
Intervention: Modest reduction in salt intake from 9.7 to 6.5 g/day
Number of subjects: 169
Study: 17435354

Group type: EXPERIMENTAL
Intervention: Forest area group (6 subjects)
Number of subjects: 12

Group type: COMPARATOR
Intervention: City area group (6 subjects)
Number of subjects: 12
Study: 16822124

Group type: EXPERIMENTAL
Intervention: Pairs of visual stimuli (626-nm LEDs) with 13 stimulus onset asynchronies
Number of subjects: 0
Study: 12797717

Group type: EXPERIMENTAL
Intervention: English version completed first, followed by Chinese version (same occasion)
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Chinese version completed first, followed by English version (same occasion)
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: English version completed once and then again 1-week later
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Chinese version completed once and then again 1-week later
Number of subjects: 309

Group type: COMPARATOR
Intervention: Both versions of the SF-36
Number of subjects: 309
Study: 10821362

Group type: EXPERIMENTAL
Intervention: High-dose L-folinic acid (175 mg)
Number of subjects: 4927

Group type: EXPERIMENTAL
Intervention: Low-dose L-folinic acid (25 mg)
Number of subjects: 4927

Group type: EXPERIMENTAL
Intervention: Levamisole (50 mg)
Number of subjects: 4927

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4927
Study: 8669651

Group type: EXPERIMENTAL
Intervention: Low-dose ketamine by subcutaneous infusion (0.1 mg/kg/h)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intermittent morphine (0.1 mg/kg intravenously, four‐hourly)
Number of subjects: 40
Study: 1900254

Group type: EXPERIMENTAL
Intervention: 3 MU of alpha-interferon given three times a week for 24 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1 MU of alpha-interferon given three times a week for 24 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 60
Study: 6341478

Group type: EXPERIMENTAL
Intervention: Varicella-zoster immune globulin (VZIG)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Zoster immune globulin (ZIG)
Number of subjects: 164
Study: 31812149

Group type: EXPERIMENTAL
Intervention: EG-1962 (sustained-release nimodipine) - 100-1200 mg as a single intraventricular injection
Number of subjects: 72

Group type: COMPARATOR
Intervention: Oral nimodipine
Number of subjects: 72
Study: 27597563

Group type: EXPERIMENTAL
Intervention: Early infant circumcision (EIC) performed by clinical officers (COs)
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Early infant circumcision (EIC) performed by registered nurse midwives (RNMWs)
Number of subjects: 501
Study: 25894914

Group type: EXPERIMENTAL
Intervention: TruView video laryngoscope
Number of subjects: 120

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 120
Study: 23350795

Group type: EXPERIMENTAL
Intervention: Insulin glargine, final mean dosage 0.44 units/kg, treatment duration 6 months
Number of subjects: 2251

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 2251
Study: 20628767

Group type: EXPERIMENTAL
Intervention: Patient-Specific Functional Scale (PSFS)
Number of subjects: 831

Group type: COMPARATOR
Intervention: Roland Morris Disability Questionnaire (RMDQ)
Number of subjects: 831
Study: 19678812

Group type: EXPERIMENTAL
Intervention: Oral bisacodyl (5 mg p.o. per day)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 17432642

Group type: EXPERIMENTAL
Intervention: Improved acupoints and rehabilitation exercise (Group A)
Number of subjects: 578

Group type: COMPARATOR
Intervention: Rehabilitation exercise (Group B)
Number of subjects: 578

Group type: COMPARATOR
Intervention: Routine acupoints and rehabilitation exercise (Group C)
Number of subjects: 578

Group type: COMPARATOR
Intervention: Medication (Group D)
Number of subjects: 578
Study: 15589083

Group type: EXPERIMENTAL
Intervention: Self-reported pain by persons with dementia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caregiver reports of pain in care recipients with dementia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dyadic congruence of pain reports
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Factors predicting congruence of pain reports
Number of subjects: 0
Study: 11569692

Group type: EXPERIMENTAL
Intervention: Alosetron 1 mg twice daily
Number of subjects: 801
Study: 9211136

Group type: EXPERIMENTAL
Intervention: Education program (video and brochures)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unexposed group (no education program)
Number of subjects: 0
Study: 8181022

Group type: EXPERIMENTAL
Intervention: Early intervention to prevent heart failure and progression of cardiac dysfunction
Number of subjects: 0
Study: 3325259

Group type: EXPERIMENTAL
Intervention: ofloxacin 800 mg once daily for 7 days
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: enoxacin
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: pefloxacin
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: ciprofloxacin
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: various new oral quinolones
Number of subjects: 271
Study: 29338540

Group type: EXPERIMENTAL
Intervention: VR-CAP (bortezomib)
Number of subjects: 80

Group type: COMPARATOR
Intervention: R-CHOP (vincristine)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: VR-CAP
Number of subjects: 80

Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 80
Study: 27023594

Group type: EXPERIMENTAL
Intervention: 18% of calories from high fructose corn syrup (HFCS)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: 18% of calories from sucrose
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: 9% of calories from fructose
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: 9% of calories from glucose
Number of subjects: 267
Study: 23958035

Group type: EXPERIMENTAL
Intervention: CRAFT (Community Restitution Apprenticeship‐Focused Training)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Education as Usual (EAU)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: CRAFT
Number of subjects: 97
Study: 23457685

Group type: EXPERIMENTAL
Intervention: Mindful attention
Number of subjects: 82

Group type: COMPARATOR
Intervention: Guided imagery
Number of subjects: 82
Study: 19901102

Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg twice daily
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Pregabalin 75 mg twice daily
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study: 18436904

Group type: EXPERIMENTAL
Intervention: Computer-triggered decision support
Number of subjects: 3449

Group type: COMPARATOR
Intervention: On-demand drug review
Number of subjects: 3449
Study: 16571160

Group type: EXPERIMENTAL
Intervention: Modified sham feeding (MSF) with olive oil
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Modified sham feeding (MSF) with linoleic oil
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Modified sham feeding (MSF) with oleic oil
Number of subjects: 36

Group type: COMPARATOR
Intervention: Water ingestion
Number of subjects: 36
Study: 12610718

Group type: EXPERIMENTAL
Intervention: Immediate initiation of 30 mg/day aripiprazole with simultaneous immediate discontinuation of current antipsychotic
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immediate initiation of 30 mg/day aripiprazole while tapering off current antipsychotic over 2 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Up-titrating aripiprazole to 30 mg/day over 2 weeks while simultaneously tapering off current antipsychotic
Number of subjects: 0
Study: 10639540

Group type: EXPERIMENTAL
Intervention: 400 IU of vitamin E daily from natural sources
Number of subjects: 9541

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 9541
Study: 9185732

Group type: EXPERIMENTAL
Intervention: Multihole fine-needle aspiration (FNA) biopsy
Number of subjects: 88

Group type: COMPARATOR
Intervention: Single-hole fine-needle aspiration (FNA) biopsy
Number of subjects: 88
Study: 1347973

Group type: EXPERIMENTAL
Intervention: 0.5% apraclonidine hydrochloride with 16-microliters drop size
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1% apraclonidine solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Formulation with hydroxypropylmethylcellulose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Formulations with hydroxypropylmethylcellulose or lysolecithin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3157894

Group type: EXPERIMENTAL
Intervention: Non-steroidal anti-inflammatory drug (NSAID)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Conservative physiotherapy
Number of subjects: 112

Group type: COMPARATOR
Intervention: Manipulative physiotherapy
Number of subjects: 112
Study: 31919989

Group type: EXPERIMENTAL
Intervention: Nintedanib (tyrosine-kinase inhibitor)
Number of subjects: 1061
Study: 30020209

Group type: EXPERIMENTAL
Intervention: Multiple suicide attempts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single suicide attempts
Number of subjects: 0
Study: 28843718

Group type: EXPERIMENTAL
Intervention: PerClot®
Number of subjects: 51

Group type: COMPARATOR
Intervention: Standard-of-care
Number of subjects: 51
Study: 25447355

Group type: EXPERIMENTAL
Intervention: Prehospital cooling with a surface cooling pad for 24 hours
Number of subjects: 110

Group type: COMPARATOR
Intervention: In-hospital cooling for 24 hours
Number of subjects: 110
Study: 24035211

Group type: EXPERIMENTAL
Intervention: Topical nifedipine along with conventional treatment
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Oral nifedipine and conventional treatment
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 90
Study: 21389845

Group type: EXPERIMENTAL
Intervention: Modified constraint‐induced movement therapy (3 hrs/day, 5 days/wk for 4 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: General upper limb exercises (3 hrs/day, 5 days/wk for 4 weeks)
Number of subjects: 20